PRESS RELEASE published on 01/24/2025 at 07:00, 1 year 9 months ago BB Biotech: Preliminary full-year 2024 results and dividend proposal BB Biotech AG reports preliminary full-year 2024 results with a net profit of CHF 76 mn, proposing a dividend of CHF 1.80 per share at the AGM on March 19, 2025, focusing on shareholder returns and biotech sector growth Preliminary Results Dividend Proposal Biotech Sector Shareholder Returns BB Biotech
PRESS RELEASE published on 01/24/2025 at 07:00, 1 year 9 months ago EQS-Adhoc: BB Biotech AG closes the 2024 fiscal year with a profit BB Biotech AG closes the 2024 fiscal year with a profit of approximately CHF 76 million, reflecting share price development. Preliminary unaudited figures show a significant improvement from the previous year Investment Company Preliminary Figures BB Biotech AG Profit 2024 Fiscal Year
BRIEF published on 01/22/2025 at 14:36, 1 year 9 months ago Edison Highlights BB Biotech's Portfolio Boost Acquisition Net Asset Value Investment Biotech Sector BB Biotech
PRESS RELEASE published on 01/22/2025 at 14:31, 1 year 9 months ago Edison issues report on BB Biotech (BION) Edison issues report on BB Biotech (BION) highlighting recent positive developments and implications for the biotech sector. Johnson & Johnson's acquisition of Intra-Cellular Therapies at a premium has boosted BB Biotech's net asset value Acquisition Edison Biotech Sector BB Biotech Johnson & Johnson
BRIEF published on 10/25/2024 at 07:05, 2 years ago BB Biotech AG Releases Interim Report with Positive Net Profit Investment Net Profit Biotech Sector Interim Report BB Biotech
BRIEF published on 10/25/2024 at 07:05, 2 years ago BB Biotech: Strategic Portfolio Reallocation Amid Volatile Markets Financial Results Investment Strategy Biotech Sector BB Biotech Portfolio Reallocation
PRESS RELEASE published on 10/25/2024 at 07:00, 2 years ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report for the first nine months of 2024, showing a net profit and strategic investment details Investment Company Net Profit BB Biotech AG Interim Report Stocks
PRESS RELEASE published on 10/25/2024 at 07:00, 2 years ago BB Biotech: Strategic reallocation of portfolio assets progressing BB Biotech AG reports strategic portfolio reallocation progress in Q3 2024 amid market volatility, focusing on promising biotech investments. Key companies achieve milestones Investment BB Biotech AG Biotech Sector Milestones Portfolio Reallocation
BRIEF published on 10/23/2024 at 10:17, 2 years ago BB Biotech Sees Positive Developments Amid Sector Challenges Investment Opportunity Biotech Sector BB Biotech Share Price Discount RNA Editing
PRESS RELEASE published on 10/23/2024 at 10:12, 2 years ago Edison issues report on BB Biotech (BION) Edison releases report on BB Biotech, highlighting positive developments in genetic medicine and revenue prospects, offering investment opportunity at a wide discount Investment Opportunity Edison Discount BB Biotech Genetic Medicine
Published on 11/06/2026 at 13:00, 8 hours 27 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 8 hours 57 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 8 hours 57 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 05:15, 16 hours 12 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 20:15, 1 hour 12 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 2 hours 12 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 2 hours 27 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 2 hours 55 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 3 hours 27 minutes ago ARVERNE GROUP: Number shares and voting rights
Published on 11/06/2026 at 18:00, 3 hours 27 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 3 hours 33 minutes ago Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 3 hours 52 minutes ago Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
